Talis Biomedical Corporation Sustainability Profile
Talis Biomedical Corporation, often referred to as Talis Bio, is a pioneering company headquartered in the United States, specialising in molecular diagnostics. Founded in 2013, Talis Bio has made significant strides in the healthcare industry, particularly in the development of rapid, point-of-care testing solutions for infectious diseases. The company’s flagship product, the Talis One platform, stands out for its ability to deliver accurate results in under an hour, making it a vital tool for clinicians. Talis Bio's innovative approach positions it as a leader in the diagnostics market, with a focus on enhancing patient care through timely and precise testing. With a commitment to advancing healthcare technology, Talis Biomedical Corporation continues to shape the future of diagnostics.
DitchCarbon Score
How does Talis Biomedical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Talis Biomedical Corporation's score of 23 is lower than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Talis Biomedical Corporation's reported carbon emissions
Talis Biomedical Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Talis Biomedical may not have established formal commitments to reduce its carbon footprint or engage in climate initiatives at this time. As the company operates within an industry increasingly focused on sustainability, it may benefit from developing and communicating clear climate commitments to align with broader environmental goals.
How Carbon Intensive is Talis Biomedical Corporation's Industry?
How Carbon Intensive is Talis Biomedical Corporation's Location?
Talis Biomedical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Talis Biomedical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
